Cited by 160Sirtuins and Resveratrol in MedicineAdipose Tissue and MetabolismNuclear Receptors and Signaling

Novel Role of the SIRT1 in Endocrine and Metabolic Diseases

Open access
Lu, Chenxi, Zhao, Huadong, Liu, Yanqing, Yang, Zhi, Yao, Hairong, Liu, Tong, Gou, Tiantian, Wang, Li +4 more·2023·International Journal of Biological Sciences

Abstract

-dependent deacetylase, is a cellular regulator that has received extensive attention in recent years and regarded as a sensor of cellular energy and metabolism. The accumulated evidence suggests that SIRT1 is involved in the development of endocrine and metabolic diseases. In a variety of organisms, SIRT1 regulates gene expression through the deacetylation of histone, transcription factors, and lysine residues of other modified proteins including several metabolic and endocrine signal transcription factors, thereby enhancing the therapeutic effects of endocrine and metabolic diseases. These evidences indicate that targeting SIRT1 has promising applications in the treatment of endocrine and metabolic diseases. This review focuses on the role of SIRT1 in endocrine and metabolic diseases. First, we describe the background and structure of SIRT1. Then, we outline the role of SIRT1 in endocrine and metabolic diseases such as hyperuricemia, diabetes, hypertension, hyperlipidemia, osteoporosis, and polycystic ovarian syndrome. Subsequently, the SIRT1 agonists and inhibitors in the above diseases are summarized and future research directions are proposed. Overall, the information presents here may highlight the potential of SIRT1 as a future biomarker and therapeutic target for endocrine and metabolic diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7150/ijbs.78654

Cites

248 of 248 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These adaptations are mediated by a network of molecular signals including AMPK, SIRT1, PPARs, and PGC-1α, which modulate cellular energy metabolism, oxidative capacity, and metabolic homeostasis.

    “These adaptations are mediated by a network of molecular signals, including AMP-activated protein kinase (AMPK), sirtuins (particularly SIRT1), peroxisome proliferator-activated receptors (PPARs), and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), which collectively modulate cellular energy metabolism, oxidative capacity, and metabolic homeostasis [7,8].”

    From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [7]

    The Introduction (page not provided) links SIRT1 with AMPK, PPARγ, and PGC-1α in glucose and lipid metabolism, and the Conclusion and Perspectives links SIRT1 pathways with oxidative stress and mitochondrial damage. The paper supports the metabolic-signaling portion of the claim, but these passages do not establish that the network collectively mediates the cited adaptations or modulates oxidative capacity specifically. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

4 of the 252 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [65]Da L Xueqing W Wei W Chenghao M Baoqing P Shuqin W Synthesis and Application of Iron Oxide Nanoparticles in Bone Tissue Repair %J Journal of Nanomaterials 2021 2021
  2. [173]Bruckbauer A Banerjee J Cao Q Cui X Jing J Zha L Erratum: Leucine-nicotinic acid synergy stimulates AMPK/Sirt1 signaling and regulates lipid metabolism and lifespan in Caenorhabditis elegans, and hyperlipidemia and atherosclerosis in mice American journal of cardiovascular disease 2017 7 97 28804683 PMC5545211

Cited by

Sorted by citations

Authors
Lu, C., Zhao, H., Liu, Y., Yang, Z., Yao, H., Liu, T., Gou, T., Wang, L., Zhang, J., Tian, Y., Yang, Y., & Zhang, H.
Affiliations
Northwest University (CN)
Corresponding author
Zhang, Huan
Venue
International Journal of Biological Sciences
Published
2023
Volume
19
Issue
2
Pages
484-501
ISSN
1449-2288 (ISSN-L)
OpenAlex
W4311863315
Cited by
160
References
252
Citations by year
2026: 52 · 2025: 54 · 2024: 39 · 2023: 15
FWCI
3.85
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • International Journal of Biological Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Strong
  • National Natural Science Foundation of China (21YXYJ0037, and 82070422, 81871607, 82070422)
  • Key Research and Development Projects of Shaanxi Province (2020ZDLSF04-03)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
SIRT1, sirtuins, histone deacetylase, endocrine disorders, metabolic disorders, hyperuricemia, diabetes mellitus, hypertension, hyperlipidemia, osteoporosis, polycystic ovary syndrome, SIRT1 agonist, SIRT1 inhibitors, therapeutic target, biomarkers
MeSH terms
Endocrine System Diseases, Histones, Humans, Metabolic Diseases, Transcription Factors, Biomarkers, Sirtuin 1, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review